                         SEQUENCE LISTING

<110>  Yeda Research and Development Co. Ltd.
       SAGI, Irit
       MOHAN, Vishnu
 
<120>  ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) INHIBITORY ANTIbody AND 
       USES THEREOF

<130>  81393

<150>  IL 264768
<151>  2019-02-10

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  112
<212>  PRT
<213>  Artificial sequence

<220>
<223>  GSM-192 Light Chain Sequence

<400>  1

Asp Ile Val Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly Gln 
1               5                   10                  15      


Arg Ala Thr Ile Ser Cys Arg Ala Ser Glu Ser Phe Asp Ser Tyr Gly 
            20                  25                  30          


Asn Thr Phe Val His Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Leu Val Ser Asn Leu Glu Ser Gly Val Pro Ala Gly 
    50                  55                  60                  


Phe Arg Gly Arg Gly Ser Arg Thr Asp Phe Thr Leu Thr Ile Asp Pro 
65                  70                  75                  80  


Val Glu Ala Asp Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Asn Asn Glu 
                85                  90                  95      


Asp Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala 
            100                 105                 110         


<210>  2
<211>  119
<212>  PRT
<213>  Artificial sequence

<220>
<223>  GSM-192 Heavy Chain Sequence

<400>  2

Glu Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Ile Pro Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Asn Met Asp Trp Met Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile 
        35                  40                  45              


Gly His Ile Asn Pro Asn Asn Gly Gly Thr Phe Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Asp Lys Ala Thr Phe Ile Val Asp Lys Ser Ser Asn Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Gly Gly Gly Leu Arg Arg Gly Pro Phe Ala Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser 
        115                 


<210>  3
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  complementarity determining region (CDR) amino acid sequences

<400>  3

Ala Ser Glu Ser Phe Asp Ser Tyr Gly Asn Thr Phe Val His 
1               5                   10                  


<210>  4
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  complementarity determining region (CDR) amino acid sequences

<400>  4

Leu Val Ser Asn Leu Glu 
1               5       


<210>  5
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  complementarity determining region (CDR) amino acid sequences

<400>  5

Gln Gln Asn Asn Glu Asp Pro Tyr 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  complementarity determining region (CDR) amino acid sequences

<400>  6

Gly Tyr Thr Phe Thr Asp Tyr Asn 
1               5               


<210>  7
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  complementarity determining region (CDR) amino acid sequences

<400>  7

His Ile Asn Pro Asn Asn Gly Gly Thr Phe 
1               5                   10  


<210>  8
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  complementarity determining region (CDR) amino acid sequences

<400>  8

Gly Gly Gly Leu Arg Arg Gly Pro 
1               5               


<210>  9
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Biotin ligase tag amino acid sequence

<400>  9

Leu His His Ile Leu Asp Ala Gln Lys Met Val Trp Asn His Arg 
1               5                   10                  15  


<210>  10
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  fluorogenic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Mca [ (7-Methoxycoumarin-4-yl)acetyl] conjugated

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X= Dpa: N-3-(2, 4-Dinitrophenyl)-L-2,3-diaminopropionyl

<400>  10

Pro Leu Gly Leu Xaa Ala Arg 
1               5           


